Virbac S.A. (VIRP) is a Drug manufacturers general company in the Healthcare sector, listed on Euronext Paris. This page provides the complete earnings calendar, dividend schedule, and financial data for Virbac S.A. in 2026. The next earnings report is expected on September 17, 2026.
Next earnings date
17 Sep 2026
In 26 days
EPS estimate
—
Revenue estimate
877.1M
Past earnings
Latest earnings analysis
Consensus estimates were not available to assess Virbac S.A.'s results, with revenue of USD 869.71 million and no EPS disclosed. No prior report is available for comparison.
Next ex-dividend
—
Not scheduled
Next payment
—
Not scheduled
Dividend amount
—
Not available
Past dividends
| Ex-dividend | Payment | Amount |
|---|---|---|
| 02 Jul 2026 | 06 Jul 2026 | 1.66 |
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Virbac S.A. (VIRP) is scheduled to report earnings on September 17, 2026.
Virbac S.A. (VIRP) last reported earnings on September 12, 2025.
Virbac S.A. (VIRP) is listed on Euronext Paris.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.